CX Institutional’s Harmony Biosciences HRMY Stock Holding History

CX Institutional’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.45M	Buy	259,496 +14,809	+6%	+$467K	0.27%	82
2026 Q1	$6.85M	Sell	244,687 -31,122	-11%	-$1.02M	0.21%	114
2025 Q4	$10.3M	Buy	275,809 +45,376	+20%	+$1.49M	0.31%	75
2025 Q3	$6.35M	Buy	230,433 +22,650	+11%	+$780K	0.19%	126
2025 Q2	$6.57M	Buy	207,783 +129,916	+167%	+$4.18M	0.23%	100
2025 Q1	$2.58M	Buy	+77,867	New	+$2.79M	0.1%	167

Other funds holding HRMY

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return